Brett Delahunt

University of Otago

Papers

2

Total Citations

74

H-Index

2

About

Brett Delahunt is a leading figure in urological pathology, with a research focus that bridges prostate cancer diagnostics and histopathological outcomes. His major contributions center on the comparative predictive value of advanced imaging modalities, specifically multiparametric magnetic resonance imaging (mpMRI) and ⁶⁸Ga-PSMA PET/CT scans, for assessing pathological results after radical prostatectomy. In his most cited work (69 citations), Delahunt demonstrated how these imaging techniques can preoperatively predict tumor characteristics and guide surgical management, including pelvic lymph node dissection. This research has direct clinical implications, helping to refine patient selection for aggressive treatment versus active surveillance. His related study on 1,197 men with negative preoperative mpMRI lobes further underscores his commitment to improving risk stratification, showing that even low-risk patients may harbor significant pathology upon total embedding of surgical specimens. Delahunt’s work is notable for its rigorous histological correlation, advancing personalized medicine in prostate cancer care. His findings are widely referenced by urologists and pathologists, cementing his reputation as a key contributor to evidence-based diagnostic protocols that enhance treatment precision and patient outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
74
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
Histological comparison between predictive value of preoperative 3‐T multiparametric MRI and <sup>68</sup> Ga‐PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer
69 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University of Otago

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago